首页> 外文期刊>The Journal of Nuclear Medicine >Three-Dimensional Dosimetry for Radiation Safety Estimates from Intrathecal Administration
【24h】

Three-Dimensional Dosimetry for Radiation Safety Estimates from Intrathecal Administration

机译:用于鞘内行给药的辐射安全估计的三维剂量测定

获取原文
获取原文并翻译 | 示例
           

摘要

Intrathecal administration is of growing interest for drug delivery, and its utility is being increasingly investigated through imaging. In this work, the 3-dimensional Voxel-Based Internal Dosimetry Application (VIDA) and 4D Extended Cardiac Torso Phantom (XCAT) were extended to provide radiation safety estimates specific to intrathecal administration. Methods: The 3-dimensional VIDA dosimetry application Monte Carlo simulation was run using a modified XCAT phantom with additional and edited cerebrospinal fluid (CSF) regions to produce voxel-level absorbed dose per unit cumulated activity maps for 9 selected source regions. Simulation validation was performed to compare absorbed dose estimates for common organs in a preexisting dosimetry tool (OLINDA/EXM). Dynamic planar imaging data were acquired in 6 healthy subjects using administered volumes of 5 or 15 mL (n = 3 each) of 185 MBq of Tc-99m-diethylenetriaminepentaacetic acid. Absorbed dose was estimated for each subject using the intrathecal-specific dosimetry application. Results: Simulation results were within 6% of OLINDA estimates for common organs. Absorbed dose estimates were highest (0.3-0.8 mGy/MBq) in the lumbar CSF space. A whole-body effective dose estimate of 0.003 mSv/MBq was observed. An administered volume dependency was observed with a 15-mL volume, resulting in lower absorbed dose estimates for several intrathecal and nonintrathecal regions. Conclusion: The intrathecal-specific VIDA implementation enables tailored dosimetry estimation for regions most relevant in intrathecal administration. Absorbed doses are highly localized to CSF and spinal regions and should be taken into consideration when designing intrathecal imaging studies. A potentially interesting relationship was observed between absorbed dose and administered volume, which merits further investigation.
机译:鞘内给药对药物递送的兴趣日益增长,并且通过成像越来越多地研究其效用。在这项工作中,延长了基于三维体素的内部剂量测定施用(VIDA)和4D扩展心脏躯干幻影(XCAT),以提供特异于鞘内给药的辐射安全估计。方法:使用具有附加和编辑的脑脊液(CSF)区域的修饰的Xcat幻像进行三维VIDA剂量测定应用蒙特卡罗模拟,以产生每单位累积活动图的体素级吸收剂量,用于9个选定的源区。进行仿真验证以比较预先存在的剂量测定工具(Olinda / Exm)中的常见器官的吸收剂量估计。使用185mL(n = 3)的185mbQ型TC-99M-二亚乙基三丙烯酸酸的施用体积,在6个健康受试者中获得动态平面成像数据。使用鞘内特异性剂量测定施用估计吸收剂量的每个受试者。结果:仿真结果占奥林达普遍常见器官估计的6%。吸收剂量估计在腰部CSF空间中是最高的(0.3-0.8迈克/ MBQ)。观察到0.003msV / MBQ的全身有效剂量估计。用15ml体积观察到施用的体积依赖性,导致几个鞘内和非变形区域的吸收剂量估计较低。结论:特定于鞘内的VIDA实施使得为鞘内行给药最相关的地区定制剂量测定估计。吸收剂量高于CSF和脊髓区域的高度局部化,并且在设计鞘内成像研究时应考虑到。在吸收剂量和施用体积之间观察到潜在有趣的关系,其优异的进一步调查。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号